1. Home
  2. AMRX vs MBIN Comparison

AMRX vs MBIN Comparison

Compare AMRX & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • MBIN
  • Stock Information
  • Founded
  • AMRX 2002
  • MBIN 1990
  • Country
  • AMRX United States
  • MBIN United States
  • Employees
  • AMRX N/A
  • MBIN N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • MBIN Major Banks
  • Sector
  • AMRX Health Care
  • MBIN Finance
  • Exchange
  • AMRX Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • AMRX 2.2B
  • MBIN 2.1B
  • IPO Year
  • AMRX N/A
  • MBIN 2017
  • Fundamental
  • Price
  • AMRX $8.39
  • MBIN $43.38
  • Analyst Decision
  • AMRX Strong Buy
  • MBIN Buy
  • Analyst Count
  • AMRX 6
  • MBIN 2
  • Target Price
  • AMRX $8.67
  • MBIN $57.00
  • AVG Volume (30 Days)
  • AMRX 1.6M
  • MBIN 206.5K
  • Earning Date
  • AMRX 08-09-2024
  • MBIN 10-24-2024
  • Dividend Yield
  • AMRX N/A
  • MBIN 0.83%
  • EPS Growth
  • AMRX N/A
  • MBIN 39.04
  • EPS
  • AMRX N/A
  • MBIN 6.55
  • Revenue
  • AMRX $2,597,992,000.00
  • MBIN $614,231,000.00
  • Revenue This Year
  • AMRX $17.40
  • MBIN N/A
  • Revenue Next Year
  • AMRX N/A
  • MBIN $2.11
  • P/E Ratio
  • AMRX N/A
  • MBIN $6.62
  • Revenue Growth
  • AMRX 12.37
  • MBIN 37.93
  • 52 Week Low
  • AMRX $3.36
  • MBIN $25.78
  • 52 Week High
  • AMRX $8.72
  • MBIN $53.27
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 61.73
  • MBIN 45.77
  • Support Level
  • AMRX $8.23
  • MBIN $44.23
  • Resistance Level
  • AMRX $8.72
  • MBIN $46.32
  • Average True Range (ATR)
  • AMRX 0.21
  • MBIN 1.36
  • MACD
  • AMRX -0.02
  • MBIN -0.03
  • Stochastic Oscillator
  • AMRX 57.69
  • MBIN 7.32

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

Share on Social Networks: